B cell depletion may lead to normalization of anti-platelet, anti-erythrocyte and antiphospholipid antibodies in systemic lupus erythematosus.
Tomietto
Paolo
P
Division of Rheumatology, Catholic University of the Sacred Heart Rome-UCSC, Rome, Italy.
Gremese
Elisa
E
Tolusso
Barbara
B
Venturini
Paolo
P
De Vita
Salvatore
S
Ferraccioli
Gianfranco
G
D000293:Adolescent; D000740:Anemia / Q000209:etiology; D017152:Antibodies, Antiphospholipid / Q000097:blood; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D001323:Autoantibodies / Q000097:blood* / Q000187:drug effects; D001402:B-Lymphocytes; D001792:Blood Platelets / Q000276:immunology; D002493:Central Nervous System Diseases / Q000209:etiology; D004912:Erythrocytes / Q000276:immunology; D005260:Female; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000150:complications / Q000276:immunology / Q000628:therapy*; D008212:Lymphocyte Depletion / Q000379:methods*; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000209:etiology; D012074:Remission Induction / Q000379:methods; D000069283:Rituximab
D017152:Antibodies, Antiphospholipid; D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D001323:Autoantibodies; D000069283:Rituximab